TimeTeller’s new kit lets patients measure their internal clock at home, enabling doctors to schedule treatments when they’re most effective and potentially cut side effects.

German startup TimeTeller has launched an at‑home saliva test that lets patients gauge their circadian rhythm, giving oncologists a new tool to time chemotherapy and other cancer therapies for maximum efficacy and reduced side effects.

How the test works

The kit includes a collection tube and a simple protocol: patients provide a saliva sample at a specific time of day, mail it to TimeTeller’s lab, and receive a report that maps their internal clock against a 24‑hour biological baseline. The analysis uses established chronobiology markers to pinpoint the peak and trough of hormone cycles that influence drug metabolism.

Clinical implications

Researchers have long known that the timing of chemotherapy can affect tumor response and toxicity. By aligning treatment schedules with a patient’s personal circadian phase, doctors aim to boost tumor kill rates while sparing healthy tissue, potentially lowering the incidence of nausea, fatigue, and neutropenia.

Early pilot studies cited by TimeTeller suggest that synchronizing drug delivery with the body’s natural rhythms can improve response rates by up to 15% compared with standard scheduling, though larger trials are needed to confirm these findings.

Availability and next steps

The saliva test is now available in Germany and select EU markets, with plans to expand to the United States later this year. TimeTeller is partnering with oncology clinics to integrate the clock report into electronic health records, enabling seamless treatment planning.

For a broader look at how chronotherapy is reshaping cancer care, explore the Technology section on uxc.news.

Read the full story in TechCrunch coverage of TimeTeller's at‑home saliva test.

Track coverage on Momentum · More in Technology.